factors to consider when treating aml and the importance of communicating with patients
Published 2 years ago • 50 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
2:17
understanding the molecular complexity of aml
-
0:42
factors to consider when selecting patients with multiple myeloma for treatment with bispecifics
-
2:34
the evolution of the aml treatment paradigm
-
1:38
the importance of targeting tp53 in aml and agents being explored
-
1:29
factors that prevent the personalization of therapies in aml
-
4:15
tom de young | acute myeloid leukaemia (aml) | spot leukaemia
-
2:32
how quickly does aml progress? #aml
-
16:04
acute lymphoblastic leukemia (all) - symptoms, pathogenesis, diagnosis - down syndrome - hematology
-
1:42
novel treatment combinations in aml: what’s to come?
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
2:01
how do i know if i'm responding to a treatment? what tests are used to determine a response? #aml
-
2:06
what factors contribute to the development of therapy-related aml or mds?
-
1:25
factors that contribute to treatment decisions in acute myeloid leukemia
-
3:14
determining the optimal frontline treatment of aml
-
1:17
combination therapy for the treatment of aml
-
3:37
the future of aml treatment
-
0:57
potential approval of quizartinib in aml & its place in the aml treatment regimen
-
3:24
molecular profiling to determine treatment for all and aml
-
2:11
the current role of immuno-oncology in aml and future outlooks
-
8:29
aml causes and risk factors
-
2:25
what are the broad categories of clinical trials currently underway for aml and mds? #aml